Verapamil and propranolol

A comparison of two antihypertensive agents

G. Leonetti, C. Pasotti, G. P. Ferrari, A. Zanchetti

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Verapamil, a calcium antagonist, was compared with propranolol, a widely used beta-adrenoreceptor blocker, in hypertensive patients with respect to its antihypertensive efficacy and incidence and severity of adverse effects. Both drugs caused similar blood pressure reductions without interfering with pulse pressure. The hypotensive effect of verapamil was not accompanied by any effect on heart rate, while after verapamil there was a significant bradycardia. ST-segment and T wave abnormalities at rest and after aldosterone were partially or completely reverted by both drugs. The incidence and severity of adverse effects was very low and no patient was withdrawn from the study because of complaints due to the active drugs. Verapamil can be compared as antihypertensive drug to the beta-blocker propranolol and thus may justify, together with the absence of negative effects on lipids, blood suger, serum electolytes and renal function, its use as an antihypertensive drug of first choice.

Original languageEnglish
Pages (from-to)137-141
Number of pages5
JournalActa Medica Scandinavica
Volume215
Issue numberSUPPL. 681
Publication statusPublished - 1984

Fingerprint

Verapamil
Propranolol
Antihypertensive Agents
Pharmaceutical Preparations
Blood Pressure
Incidence
Bradycardia
Aldosterone
Heart Rate
Calcium
Kidney
Lipids
Serum

ASJC Scopus subject areas

  • Internal Medicine
  • Medicine(all)

Cite this

Leonetti, G., Pasotti, C., Ferrari, G. P., & Zanchetti, A. (1984). Verapamil and propranolol: A comparison of two antihypertensive agents. Acta Medica Scandinavica, 215(SUPPL. 681), 137-141.

Verapamil and propranolol : A comparison of two antihypertensive agents. / Leonetti, G.; Pasotti, C.; Ferrari, G. P.; Zanchetti, A.

In: Acta Medica Scandinavica, Vol. 215, No. SUPPL. 681, 1984, p. 137-141.

Research output: Contribution to journalArticle

Leonetti, G, Pasotti, C, Ferrari, GP & Zanchetti, A 1984, 'Verapamil and propranolol: A comparison of two antihypertensive agents', Acta Medica Scandinavica, vol. 215, no. SUPPL. 681, pp. 137-141.
Leonetti G, Pasotti C, Ferrari GP, Zanchetti A. Verapamil and propranolol: A comparison of two antihypertensive agents. Acta Medica Scandinavica. 1984;215(SUPPL. 681):137-141.
Leonetti, G. ; Pasotti, C. ; Ferrari, G. P. ; Zanchetti, A. / Verapamil and propranolol : A comparison of two antihypertensive agents. In: Acta Medica Scandinavica. 1984 ; Vol. 215, No. SUPPL. 681. pp. 137-141.
@article{5c3c1cf758cb42f0843698e0057c0349,
title = "Verapamil and propranolol: A comparison of two antihypertensive agents",
abstract = "Verapamil, a calcium antagonist, was compared with propranolol, a widely used beta-adrenoreceptor blocker, in hypertensive patients with respect to its antihypertensive efficacy and incidence and severity of adverse effects. Both drugs caused similar blood pressure reductions without interfering with pulse pressure. The hypotensive effect of verapamil was not accompanied by any effect on heart rate, while after verapamil there was a significant bradycardia. ST-segment and T wave abnormalities at rest and after aldosterone were partially or completely reverted by both drugs. The incidence and severity of adverse effects was very low and no patient was withdrawn from the study because of complaints due to the active drugs. Verapamil can be compared as antihypertensive drug to the beta-blocker propranolol and thus may justify, together with the absence of negative effects on lipids, blood suger, serum electolytes and renal function, its use as an antihypertensive drug of first choice.",
author = "G. Leonetti and C. Pasotti and Ferrari, {G. P.} and A. Zanchetti",
year = "1984",
language = "English",
volume = "215",
pages = "137--141",
journal = "Acta Medica Scandinavica",
issn = "0001-6101",
publisher = "Almgvist & Wiksells",
number = "SUPPL. 681",

}

TY - JOUR

T1 - Verapamil and propranolol

T2 - A comparison of two antihypertensive agents

AU - Leonetti, G.

AU - Pasotti, C.

AU - Ferrari, G. P.

AU - Zanchetti, A.

PY - 1984

Y1 - 1984

N2 - Verapamil, a calcium antagonist, was compared with propranolol, a widely used beta-adrenoreceptor blocker, in hypertensive patients with respect to its antihypertensive efficacy and incidence and severity of adverse effects. Both drugs caused similar blood pressure reductions without interfering with pulse pressure. The hypotensive effect of verapamil was not accompanied by any effect on heart rate, while after verapamil there was a significant bradycardia. ST-segment and T wave abnormalities at rest and after aldosterone were partially or completely reverted by both drugs. The incidence and severity of adverse effects was very low and no patient was withdrawn from the study because of complaints due to the active drugs. Verapamil can be compared as antihypertensive drug to the beta-blocker propranolol and thus may justify, together with the absence of negative effects on lipids, blood suger, serum electolytes and renal function, its use as an antihypertensive drug of first choice.

AB - Verapamil, a calcium antagonist, was compared with propranolol, a widely used beta-adrenoreceptor blocker, in hypertensive patients with respect to its antihypertensive efficacy and incidence and severity of adverse effects. Both drugs caused similar blood pressure reductions without interfering with pulse pressure. The hypotensive effect of verapamil was not accompanied by any effect on heart rate, while after verapamil there was a significant bradycardia. ST-segment and T wave abnormalities at rest and after aldosterone were partially or completely reverted by both drugs. The incidence and severity of adverse effects was very low and no patient was withdrawn from the study because of complaints due to the active drugs. Verapamil can be compared as antihypertensive drug to the beta-blocker propranolol and thus may justify, together with the absence of negative effects on lipids, blood suger, serum electolytes and renal function, its use as an antihypertensive drug of first choice.

UR - http://www.scopus.com/inward/record.url?scp=0021324670&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021324670&partnerID=8YFLogxK

M3 - Article

VL - 215

SP - 137

EP - 141

JO - Acta Medica Scandinavica

JF - Acta Medica Scandinavica

SN - 0001-6101

IS - SUPPL. 681

ER -